Related Experiment Video
Updated: Nov 6, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
The Regulating Effect of Autophagy-Related MiRNAs in Kidney, Bladder, and Prostate Cancer
Kai Huang1, Xiaoxin Sun2, Haotian Wu1
1Department of Urology, First Affifiliated Hospital of Dalian Medical University, Dalian, China.
Abstract:
Autophagy is a treatment target for many disorders, including cancer, and its specific role is becoming increasingly well known. In tumors, researchers pay attention to microribonucleic acids (miRNAs) with regulatory effects to develop more effective therapeutic drugs for autophagy and find new therapeutic targets. Various studies have shown that autophagy-related miRNAs play an irreplaceable role in different tumors, such as miR-495, miR-30, and miR-101. These miRNAs are associated with autophagy resistance in gastric cancer, non-small cell lung cancer, and cervical cancer. In recent years, autophagy-related miRNAs have also been reported to play a role in autophagy in urinary system tumors. This article reviews the regulatory effects of autophagy-related miRNAs in kidney, bladder, and prostate cancer and provides new ideas for targeted therapy of the three major tumors of the urinary system.
Insights
Autophagy-related microRNAs (miRNAs) are crucial in cancer, including urinary system tumors. This review explores their regulatory roles in kidney, bladder, and prostate cancers, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Autophagy is a key cellular process and a therapeutic target for various diseases, notably cancer.
- MicroRNAs (miRNAs) are increasingly recognized for their regulatory roles in cancer development and treatment.
- Autophagy-related miRNAs have demonstrated significant involvement in multiple cancer types, influencing treatment resistance.
Purpose of the Study:
- To review the regulatory functions of autophagy-related miRNAs in urinary system tumors.
- To identify novel therapeutic targets for kidney, bladder, and prostate cancers.
- To provide insights into the role of miRNAs in modulating autophagy within the urinary tract.
Main Methods:
- Literature review of studies on autophagy, miRNAs, and urinary system cancers.
- Analysis of specific autophagy-related miRNAs (e.g., miR-495, miR-30, miR-101) and their targets.
- Synthesis of current research on miRNA-mediated autophagy regulation in kidney, bladder, and prostate cancer.
Main Results:
- Autophagy-related miRNAs play a significant role in the progression and resistance of gastric, lung, and cervical cancers.
- Emerging evidence highlights the involvement of these miRNAs in the autophagy of kidney, bladder, and prostate cancers.
- Specific miRNAs are associated with autophagy modulation in these urinary system malignancies.
Conclusions:
- Autophagy-related miRNAs represent promising therapeutic targets for urinary system cancers.
- Understanding miRNA-autophagy interactions can lead to innovative treatment strategies for kidney, bladder, and prostate cancer.
- Further research into these miRNAs may unlock new avenues for targeted cancer therapy.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Abnormal Proliferation

